The longstanding debate over whether butter or olive oil constitutes a healthier dietary fat has reignited as new perspectives challenge conventional nutritional advice. Traditionally, medical experts have recommended replacing butter with olive oil due to its lower saturated fat content and association with improved heart health. Butter, rich in saturated fats, has been linked to elevated low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—which raises the risk of cardiovascular events such as heart attacks and strokes. Olive oil, especially extra-virgin varieties, is believed to increase high-density lipoprotein (HDL) cholesterol, known as “good” cholesterol, and forms a fundamental component of the Mediterranean diet, which numerous studies have connected with reduced cardiovascular risk and longer lifespan.

However, recent discussions fueled by social media proponents and some policymakers have questioned the extent to which butter is detrimental. Notably, Robert F. Kennedy, the US Health Secretary recognized for his unconventional stance on healthcare, endorsed dietary recommendations advocating for increased intake of saturated fats, including butter. Kennedy emphasized the importance of “real food,” highlighting protein and healthy fats as essential nutrients that were improperly discouraged in former guidelines.

In an effort to shed light on the issue, a month-long dietary experiment was conducted by an individual accustomed to cooking primarily with extra-virgin olive oil. Prior to the intervention, baseline blood tests revealed a total cholesterol level of 6.5 mmol/L, higher than the NHS threshold of five, likely influenced by age-related factors. Over a five-week period, olive oil was largely replaced with substantial amounts of butter in cooking and food preparation. Despite initial concerns about potential adverse impacts, the subsequent blood work revealed only marginal shifts: LDL cholesterol marginally increased from 3.77 to 3.89 mmol/L, and HDL cholesterol slightly decreased from 2.72 to 2.32 mmol/L. These alterations were deemed not clinically significant by the attending physician, and notably, no changes in body weight were observed.

Experts indicate that these findings align with existing research on saturated fats and cardiovascular health. Professor Jules Griffin, a food researcher at the University of Aberdeen, acknowledged that while olive oil remains the superior choice due to its monounsaturated fat content, butter’s negative effects may be overstated. He explained that palmitic acid in butter can impair the body’s ability to clear LDL cholesterol, whereas olive oil’s monounsaturated fats lack this effect and may confer cardiovascular benefits. Nonetheless, the modest changes in cholesterol levels observed over a month of butter consumption suggest that moderate intake of saturated fats may not be as harmful as previously thought.

The significance of these findings comes amid ongoing public health concerns in the United Kingdom, where cardiovascular disease remains a leading cause of death—claiming approximately 175,000 lives annually. About one-quarter of these deaths are attributed to high cholesterol levels, underscoring the crucial need for clear dietary guidance. While the debate between butter and olive oil continues, current evidence emphasizes a balanced perspective rather than outright vilification of either fat source.